Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2020 2
2021 2
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Epigenetics of oral and oropharyngeal cancers.
Russo D, Merolla F, Varricchio S, Salzano G, Zarrilli G, Mascolo M, Strazzullo V, Di Crescenzo RM, Celetti A, Ilardi G. Russo D, et al. Among authors: zarrilli g. Biomed Rep. 2018 Oct;9(4):275-283. doi: 10.3892/br.2018.1136. Epub 2018 Jul 27. Biomed Rep. 2018. PMID: 30233779 Free PMC article. Review.
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer.
Miglietta F, Ragazzi M, Fernandes B, Griguolo G, Massa D, Girardi F, Bottosso M, Bisagni A, Zarrilli G, Porra F, Iannaccone D, Dore L, Gaudio M, Santandrea G, Fassan M, Lo Mele M, De Sanctis R, Zambelli A, Bisagni G, Guarneri V, Dieci MV. Miglietta F, et al. Among authors: zarrilli g. Clin Cancer Res. 2023 Sep 1;29(17):3429-3437. doi: 10.1158/1078-0432.CCR-23-0480. Clin Cancer Res. 2023. PMID: 37417941 Free PMC article.
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study.
Miglietta F, Carraro V, Amato O, Griguolo G, Bottosso M, Munari G, Zarrilli G, Lo Mele M, Barbieri C, Dei Tos AP, Guarneri V, Dieci MV, Fassan M. Miglietta F, et al. Among authors: zarrilli g. J Clin Pathol. 2023 Jun 21:jcp-2023-208856. doi: 10.1136/jcp-2023-208856. Online ahead of print. J Clin Pathol. 2023. PMID: 37344170 Free article.
Erratum: Epigenetics of oral and oropharyngeal cancers (Review).
Russo D, Merolla F, Varricchio S, Salzano G, Zarrilli G, Mascolo M, Strazzullo V, Crescenzo RMD, Celetti A, Ilardi G. Russo D, et al. Among authors: zarrilli g. Biomed Rep. 2020 May;12(5):290. doi: 10.3892/br.2020.1290. Epub 2020 Mar 6. Biomed Rep. 2020. PMID: 32257193 Free PMC article.
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series.
Zarrilli G, Angerilli V, Cappellesso R, Galuppini F, Pennelli G, Farinati F, Nicolè L, Savarino E, Realdon S, Griguolo G, Bottosso M, Dieci MV, Guarneri V, Dei Tos AP, Lo Mele M, Fassan M. Zarrilli G, et al. Pathol Res Pract. 2022 May;233:153872. doi: 10.1016/j.prp.2022.153872. Epub 2022 Apr 1. Pathol Res Pract. 2022. PMID: 35390634
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Dieci MV, Carbognin L, Miglietta F, Canino F, Giorgi CA, Cumerlato E, Amato O, Massa D, Griguolo G, Genovesi E, Garufi G, Giannarelli D, Tornincasa A, Trudu L, Michieletto S, Saibene T, Lo Mele M, Fassan M, Zarrilli G, Piacentini F, Bria E, Guarneri V. Dieci MV, et al. Among authors: zarrilli g. Br J Cancer. 2023 Jan;128(2):266-274. doi: 10.1038/s41416-022-02050-8. Epub 2022 Nov 17. Br J Cancer. 2023. PMID: 36396818 Free PMC article.
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation.
Dieci MV, Carbognin L, Miglietta F, Canino F, Giorgi CA, Cumerlato E, Amato O, Massa D, Griguolo G, Genovesi E, Garufi G, Giannarelli D, Tornincasa A, Trudu L, Michieletto S, Saibene T, Lo Mele M, Fassan M, Zarrilli G, Piacentini F, Bria E, Guarneri V. Dieci MV, et al. Among authors: zarrilli g. Br J Cancer. 2023 Jan;128(2):398. doi: 10.1038/s41416-022-02087-9. Br J Cancer. 2023. PMID: 36460777 Free PMC article. No abstract available.